openPR Logo
Press release

Pharmerging Market is Expected to Demonstrate a CAGR of 11.3% by 2025

08-24-2018 03:12 PM CET | Health & Medicine

Press release from: Transparency Market Research

Pharmerging Market is Expected to Demonstrate a CAGR of 11.3%

Global Pharmerging Market: Snapshot

The global pharmerging market is experiencing a significant rise, especially in the emerging economies across the world. The rising prevalence of non-communicable diseases, aging population, increasing life expectancy, escalating income, surging government expenditure on health care, free trade agreement, and the constant research and development are some of the key factors behind the growth of this market.

With the increasing incidence rate of various diseases, the demand for highly innovative and better outcome products is also increasing, which is likely to result in a substantial growth of this market in the future. The continual innovation and advancements in the drugs for the treatment of a host of diseases are also anticipated to drive this market over the next few years. The global market for pharmerging, which stood at US$552.8 mn in 2015, is expected to rise at a CAGR of 11.30% between 2016 and 2024 and reach a value of US$1.40 bn by the end of 2024.

Obtain Report Details @ https://www.transparencymarketresearch.com/pharmerging-market.html

Pharmaceutical Products to Witness Strong Growth in Near Future

On the basis of type of product, pharmaceuticals and healthcare are the two main segments of the global market for pharmerging. The pharmaceuticals segment dominated the overall market in 2016 with a share of 65.2%. The scenario is expected to continue like this over the next few years, thanks to the significant rise in the demand for both, the branded as well as generic drugs.

Apart from this, the increasing number of innovative therapies for the treatment of various diseases at affordable price is also projected to boost this segment in the years to come. On the other hand, the healthcare segment is likely to be driven by the growing emphasis on medical devices used in the diagnosis and treatment of a number of diseases.

Based on the indication, the worldwide market for pharmerging has been classified into lifestyle diseases, cancers and autoimmune diseases, and infectious diseases. Among these, lifestyle-borne and cancer and autoimmune diseases are projected to offer lucrative opportunities for the growth of this market with attractiveness index over the forthcoming years.

Request For Sample of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=8200

Asia Pacific to Remain on Top

In terms of the geography, the global pharmerging market reports its presence across Latin America, the Middle East and Africa, Asia Pacific, North America, and Europe. With a share of 53%, Asia Pacific led this market in 2016. Researchers expect this regional market to remain on the top, thanks to rapid urbanization, increasing patent expiration, and the surge in the investments for medical research. China has emerged as the key domestic market for pharmerging in Asia Pacific.

Among other regional markets for pharmerging, Europe and Latin America are likely to witness healthy growth in the near future. Technological advancements, extensive research and development practices, and the increasing awareness regarding the treatment and the management of healthcare facilities are likely to propel the Latin America market. The Europe market is predicted to be drive by the large population size, growing disease prevalence, and the increasing health expenditure in the region.

Request For Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=8200

Huadong Medicine Co. Ltd., Sun Pharmaceutical Industries Ltd., Tata Consultancy Services Ltd., LUPIN, GlaxoSmithKline Plc., AstraZeneca, Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Novartis AG, Merck & Co. Inc. F. Hoffmann-La Roche Ltd., Koninklijke Philips N.V., and Abbott Laboratories are the leading players in the global pharmerging market.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmerging Market is Expected to Demonstrate a CAGR of 11.3% by 2025 here

News-ID: 1200607 • Views:

More Releases from Transparency Market Research

Automotive Thermal Management System Market Poised to Reach USD 173.8 Billion by 2036, Driven by EV Adoption and Advanced Thermal Technologies
Automotive Thermal Management System Market Poised to Reach USD 173.8 Billion by …
The global automotive thermal management system market is entering a high-growth phase, fueled by the rapid electrification of vehicles, stricter emission norms, and rising expectations for vehicle safety, comfort, and efficiency. Valued at US$ 82.6 billion in 2025, the market is projected to nearly double and reach US$ 173.8 billion by 2036, expanding at a robust CAGR of 6.8% from 2026 to 2036. Thermal management has become a mission-critical function in
Thermal-Management Exterior Coatings for High-Altitude Aircraft Market to be Worth USD 9.8 Bn by 2036 - By Coating Functionality / By Material / By End-User | U.S. • Canada • Germany • China • India
Thermal-Management Exterior Coatings for High-Altitude Aircraft Market to be Wor …
The global Thermal-Management Exterior Coatings for High-Altitude Aircraft Market was valued at US$ 1.8 Bn in 2025 and is projected to reach US$ 9.8 Bn by 2036, expanding at a robust CAGR of 17.5% during the forecast period from 2026 to 2036. Review critical insights and findings from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86920 This strong growth trajectory reflects the rising importance of advanced exterior coating technologies that ensure aircraft performance, safety,
Epithelioma Treatment Market Outlook 2035: Rising Skin Cancer Burden, Breakthrough Immunotherapies, and an 8.8% CAGR Growth Trajectory
Epithelioma Treatment Market Outlook 2035: Rising Skin Cancer Burden, Breakthrou …
The global epithelioma treatment market has entered a decisive growth phase, supported by rising cancer prevalence and rapid therapeutic innovation. In 2024, the market was valued at US$ 5.1 Bn, reflecting the growing demand for advanced diagnostic and therapeutic solutions targeting epithelial-origin tumors. Over the forecast period from 2025 to 2035, the industry is projected to expand at a robust compound annual growth rate (CAGR) of 8.8%, reaching a valuation
Tablet Hardness Testers Market to Reach USD 427.9 Mn by 2036, Driven by Rising Pharmaceutical Quality Standards
Tablet Hardness Testers Market to Reach USD 427.9 Mn by 2036, Driven by Rising P …
The Tablet Hardness Testers Market is a critical part of the pharmaceutical quality-control ecosystem. Tablet hardness testers are used to measure the mechanical strength of tablets to ensure they can withstand handling, packaging, transportation, and storage without breaking, while still dissolving correctly once ingested. As regulatory oversight becomes stricter and pharmaceutical production expands globally, the demand for accurate and reliable hardness testing equipment continues to rise. The global Tablet Hardness Testers

All 5 Releases


More Releases for Pharmerging

Pharmerging Nations Redefining Global Healthcare Growth: An In-Depth Outlook on …
The Global Pharmerging Market, valued at US$ 2.1 Bn in 2023, is set to witness rapid expansion, projected to reach US$ 7.1 Bn by 2034, growing at a strong CAGR of 11.6% from 2024 to 2034. This fast-paced growth underscores the increasing importance of pharmerging countries-an economic group representing emerging nations with accelerating pharmaceutical demand, evolving regulatory infrastructures, rising healthcare investments, and expanding patient populations. These countries, including large markets
Pharmerging Market to Witness Astonishing Growth by 2028
The Pharmerging Market size is expected to grow at an annual average of CAGR 11% during the forecast period (2023-2029). Pharmerging refers to a group of countries with low but fast growth in the pharmaceutical market. Growing healthcare spending coupled with increasing number of private hospitals is currently driving the global pharmerging market growth. In addition, high prevalence of numerous chronic diseases and increasing consumer awareness of early detection of
New Report Projects Strong Growth for Pharmerging Market
As per the market research report by TMR, in 2015, the global pharmerging market stood at US$552.8 mn and is predicted to reach a value of US$1.40 bn by 2024. The market is further anticipated to register a promising 11.30% CAGR from 2016 to 2024. In the last few years, Asia Pacific held a huge share of the pharmerging market and is estimated to remain in the same position over
Pharmerging Market : 2016 - 2024 Illuminated By New Report
Global Pharmerging Market: Snapshot The global pharmerging market is experiencing a significant rise, especially in the emerging economies across the world. The rising prevalence of non-communicable diseases, aging population, increasing life expectancy, escalating income, surging government expenditure on health care, free trade agreement, and the constant research and development are some of the key factors behind the growth of this market. View Report: https://www.transparencymarketresearch.com/pharmerging-market.html With the increasing incidence rate of various diseases, the
Pharmerging Market 2016-2024 Industry Size, Shares, Research Trends
Global Pharmerging Market: Snapshot The global pharmerging market is experiencing a significant rise, especially in the emerging economies across the world. The rising prevalence of non-communicable diseases, aging population, increasing life expectancy, escalating income, surging government expenditure on health care, free trade agreement, and the constant research and development are some of the key factors behind the growth of this market. With the increasing incidence rate of various diseases, the demand for
Global Pharmerging Market Research Report 2017
Global Pharmerging Industry 2017 Market Overview, Size, Share, Trends, Analysis, Technology, Applications, Growth, Market Status, Demands, Insights, Development, Research and Forecast 2017-2020. This report on the global Pharmerging market is a rich data repository assembled with the aim of presenting before the reader a new viewpoint on the market’s present state and estimated future growth. The report compiles vast data quantitative as well as qualitative insights into the key elements of